TScan Therapeutics, Inc.
TCRX
$1.60
-$0.12-6.98%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 290.11M | 271.12M | 297.68M | 162.78M | 192.04M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.61M | 2.97M | 1.85M | 1.94M | 2.19M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 292.72M | 274.09M | 299.53M | 164.72M | 194.24M |
|
|
|||||
| Total Current Assets | 292.72M | 274.09M | 299.53M | 164.72M | 194.24M |
| Net Property, Plant & Equipment | 71.60M | 67.10M | 68.56M | 69.43M | 71.23M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.80M | 6.84M | 6.78M | 6.68M | 6.68M |
| Total Assets | 371.12M | 348.03M | 374.87M | 240.83M | 272.15M |
|
|
|||||
| Total Accounts Payable | 4.28M | 3.65M | 3.11M | 2.12M | 2.37M |
| Total Accrued Expenses | 15.33M | 10.93M | 10.56M | 8.53M | 10.29M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.57M | 3.90M | 13.95M | 10.14M | 6.59M |
| Total Finance Division Other Current Liabilities | 11.77M | 10.18M | 10.95M | 10.69M | 10.56M |
| Total Other Current Liabilities | 11.77M | 10.18M | 10.95M | 10.69M | 10.56M |
| Total Current Liabilities | 35.96M | 28.66M | 38.57M | 31.48M | 29.82M |
|
|
|||||
| Total Current Liabilities | 35.96M | 28.66M | 38.57M | 31.48M | 29.82M |
| Long-Term Debt | 32.07M | 30.65M | 20.11M | 23.45M | 26.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 60.74M | 55.81M | 57.01M | 58.18M | 59.14M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.38M | 3.82M | 3.96M | 4.76M | 5.62M |
| Total Liabilities | 130.15M | 118.94M | 119.65M | 117.87M | 121.28M |
|
|
|||||
| Common Stock & APIC | 616.02M | 568.37M | 564.62M | 400.71M | 398.46M |
| Retained Earnings | -375.10M | -339.29M | -309.40M | -277.74M | -247.60M |
| Treasury Stock & Other | 51.00K | -- | -- | -- | -- |
| Total Common Equity | 240.97M | 229.09M | 255.22M | 122.97M | 150.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 240.97M | 229.09M | 255.22M | 122.97M | 150.87M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 240.97M | 229.09M | 255.22M | 122.97M | 150.87M |
|
|
|||||